Zeteo Biomedical LLC

Zeteo Biomedical LLC develops and commercializes advanced, patient-centric drug and biologic delivery systems, specializing in needle-free technology for pharmaceutical, biotech, and personal care applications. The company’s core offerings, the ZTECH-L and ZTECH-P platforms, support the administration of liquid, powder, and reconstituted formulations via ophthalmic, intranasal, nose-to-brain, and sublingual routes. These devices are designed for precision dosing, portability, and ease of use, featuring innovations that allow for reliable functionality in various physical orientations, including microgravity environments. The company complements its proprietary hardware with a suite of technical services, including device prototyping, analytical testing, process engineering, and support for clinical and commercial supply chain management.

By focusing on compact and intuitive design, Zeteo helps its partners improve patient adherence and medical outcomes for conditions ranging from neurodegenerative disorders and pain management to infectious diseases. The company plays a significant role in public health initiatives, having joined the Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) consortium to expedite the distribution of vaccines and biomedical countermeasures. With a robust international patent portfolio, Zeteo provides end-to-end support for drug-device combination products, aiming to maximize treatment efficacy while minimizing drug waste and environmental impact. Their services assist partners from early-stage development through to commercial-scale production and technology licensing.